Lucy Scientific Discovery, Inc.(NASDAQ:LSDI)

Lucy Scientific Discovery Inc. researches, develops, manufactures, and commercializes psychedelic products. It offers biological raw materials, crude extracts, psychotropic compounds, and active pharmaceutical ingredients (APIs). Lucy Scientific Discovery Inc. was formerly known as Hollyweed North C...
Website: https://www.lucyscientific.com
Founded: 2017
IPO Price: $4 (Feb 09, 2023)
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2023-06-30 |
|---|
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2023-06-30 |
|---|---|
assets | |
current assets | |
cash | 1,673,874 |
prepaid expenses | 1,219,180 |
accounts receivable | 7,048 |
other assets – gst receivable | 62,649 |
other receivable | 336,706 |
digital assets | |
deferred financing costs, current | 523,041 |
total current assets | 3,822,498 |
non-current assets | |
deferred financing costs, noncurrent | |
property, plant, and equipment | 764,650 |
prepaid expenses, noncurrent | 1,663,333 |
right of use asset | 1,025,033 |
intangible assets | 1,484,250 |
long-term deposits | 18,882 |
total assets | 8,778,646 |
liabilities | |
current liabilities | |
accounts payable and accrued liabilities | 1,291,063 |
convertible notes, current | |
due to related parties | 1,019,894 |
notes payable – related parties | |
notes payable, current | 60,423 |
lease liability, current | 338,819 |
total current liabilities | 2,710,199 |
non-current liabilities | |
convertible notes, noncurrent | |
lease liability, noncurrent | 1,389,558 |
notes payable, noncurrent | |
total liabilities | 4,099,757 |
stockholders’ equity | |
common stock | 48,934,278 |
accumulated deficit | -44,415,798 |
accumulated other comprehensive income | 160,409 |
total stockholders’ equity | 4,678,889 |
total liabilities and stockholders’ equity | 8,778,646 |
Cashflow Statements:
Quarterly
Annual
| Unit: USD |
|---|
